Nevro Files Patent Suit Against Stimwave
Chronic pain treatment company Nevro has filed suit against rival Stimwave Tech alleging patent infringement.
You may also be interested in...
Nevro and Boston Scientific have resolved a patent dispute involving spinal cord stimulation technologies.
In the global pain management market, spinal cord stimulation (SCS) systems are expected to continue to be the fastest-growing segment with increasing competition among device manufacturers to develop innovative, targeted therapies. In this second article of a two-part series, we'll discuss the competitive landscape in the SCS market, the key players, emerging companies and their respective technologies.
The device giant is recalling Cobalt and Crome defibrillators because they may deliver weaker shocks than intended.